Persistent epithelial defects are ocular indications that are present in ophthalmology departments. According to a publication by Maqsood et al patients had a 86% complete or partial heal rate when treated with Omnigen and OmniLenz. Read more here: http
In the recent clinical study, the average application duration with Omnigen® delivered in an outpatient setting was between 12.3 and 22.4 days for healed patients. Source: https://t.co/3cxL5cn8NH https://t.co/CGNz4eB4WJ
In May 2021, Mr Elafy et al published their paper on the management of Persistent Corneal Epithelial Defects. The study shows the wide range of aetiologies that Amniotic Membrane-Derived Dry Matrix can be used to manage. View the summary report here: htt
63% of cases of infected microbial keratitis were completely healed, according to the recent study on using Amniotic Membrane-Derived Dry Matrix (AMMDM) to treat Persistent Epithelial Defects (PEDs). Source: https://t.co/3cxL5cn8NH https://t.co/uBtHujAV
In May, Mr. Elalfy et al (QVH and Maidstone Hospitals) released a cohort study on the clinical use of AMDDM treatment for PEDs. See the full paper here: https://t.co/3cxL5cn8NH https://t.co/uBtHujAVBV https://t.co/GjQyWuVgIj
In a recent paper, @Mr Elalfy (QVH and Maidstone Hospitals) stated that Omnigen®: "Proved to have easy and simple application in the outpatient clinic setting with no storage restrictions." *depending on HTA storage license. https://t.co/3cxL5cn8NH http
Have you had the chance to read the latest study on Amniotic Membrane-Derived Dry Matrix treatment for Persistent Corneal Epithelial Defects? Mr. Elalfy et al published a cohort study on the clinical use of AMDDM treatment for PEDs: https://t.co/3cxL5cn8N
RT @WeArePioneerGrp: Fantastic results in this new report on the use of @NuVisBio's amniotic membrane-derived Dry Matrix, Omnigen® using O…
RT @WeArePioneerGrp: Fantastic results in this new report on the use of @NuVisBio's amniotic membrane-derived Dry Matrix, Omnigen® using O…
RT @WeArePioneerGrp: Fantastic results in this new report on the use of @NuVisBio's amniotic membrane-derived Dry Matrix, Omnigen® using O…
Fantastic results in this new report on the use of @NuVisBio's amniotic membrane-derived Dry Matrix, Omnigen® using OmniLenz® in treating Persistent Corneal Epithelial Defects treated Read the report > https://t.co/qduWcaOlZN #amnioticmembrane #ophth
Management of Persistent Corneal Epithelial Defects with Human Amniotic Membrane-derived Dry Matrix https://t.co/x3sPxxRIvS
Ophthopedia Update: Management of Persistent Corneal Epithelial Defects with Human Amniotic Membrane-derived Dry Matrix https://t.co/iqfGEaCQqJ #Ophthomology #Eye #Ophthotwitter